Purple Biotech (PPBT) Short-term Investments (2016 - 2026)

Purple Biotech (PPBT) has 11 years of Short-term Investments data on file, last reported at $859000.0 in Q1 2026.

• On a quarterly basis, Short-term Investments rose 1.54% year-over-year to $859000.0 in Q1 2026; TTM through Mar 2026 was $859000.0, a 1.54% increase from a year earlier, with the FY2025 full-year figure at $857000.0, up 211.64% from the prior year.
• Short-term Investments for Q1 2026 stood at $859000.0, roughly flat from $857000.0 in the prior quarter.
• Over the last five years, Short-term Investments for PPBT reached as high as $22.0 million in Q2 2022 and fell as low as $275000.0 in Q4 2024.
• Historically, Short-term Investments has averaged $4.2 million across 5 years, with a median of $849000.0 in 2023.
• Across the five-year window, Short-term Investments slumped 98.81% in 2022 and soared 211.64% in 2025, its largest moves.
• Year by year, Short-term Investments stood at $431000.0 in 2022, then soared by 97.22% to $850000.0 in 2023, then slumped by 67.65% to $275000.0 in 2024, then surged by 211.64% to $857000.0 in 2025, then rose by 0.23% to $859000.0 in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $859000.0 in Q1 2026, $857000.0 in Q4 2025, and $862000.0 in Q3 2025.